Trial intelligence / Profile preview

Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 Diabetes

NCT04949867Phase 4Completed

Sponsor
Steno Diabetes Center Copenhagen
Start
May 2021
Primary completion
Apr 2022
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of glucagon in type 1 diabetes mellitus (T1D), sponsored by Steno Diabetes Center Copenhagen. Started May 2021; status: completed.

02

Drugs

glucagon
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT04949867.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04949867.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call